T‐channel‐like pharmacological properties of highvoltage‐activated, nifedipine‐insensitive Ca2+ currents inthe rat terminal mesenteric artery
- 1 October 2002
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 137 (4), 467-476
- https://doi.org/10.1038/sj.bjp.0704892
Abstract
1. Pharmacological properties of nifedipine-insensitive, high voltage-activated Ca(2+) channels in rat mesenteric terminal arteries (NICCs) were investigated and compared with those of alpha1E and alpha1G heterologously expressed in BHK and HEK293 cells respectively, using the patch clamp technique. 2. With 10 mM Ba(2+) as the charge carrier, rat NICCs (unitary conductance: 11.5 pS with 110 mM Ba(2+)) are almost identical to those previously identified in a similar region of guinea-pig, such as in current-voltage relationship, voltage dependence of activation and inactivation, and divalent cation permeability. However, these properties are considerably different when compared with alpha1E and alpha1G. 3. SNX-482(200 nM and sFTX3.3 (1 micro M), in addition to omega-conotoxin GVIA (1 micro M) and omega-agatoxin IVA (100 nM), were totally ineffective for rat NICC currents, but significantly suppressed alpha1E (by 82% at 200 nM; IC(50)=11.1 nM) and alpha1G (by 20% at 1 micro M) channel currents, respectively. A non-specific T-type Ca(2+) channel blocker nimodipine (10 micro M) differentially suppressed these three currents (by 40, 3 and 85% for rat NICC, alpha1E and alpha1G currents, respectively). 4. Mibefradil, the widely used T-type channel blocker, almost equally inhibited rat NICC and alpha1G currents in a voltage-dependent fashion with similar IC(50) values (3.5 and 0.3 micro M and 2.4 and 0.14 micro M at -100 and -60 mV, respectively). Furthermore, other organic T-type channel blockers such as phenytoin, ethosuximide, an arylpiperidine derivative SUN N5030 (IC(50)=0.32 micro M at -60 mV for alpha1G) also exhibited comparable inhibitory efficacies for NICC currents (inhibited by 22% at 100 micro M; IC(50)=27.8 mM; IC(50)=0.53 micro M, respectively). 5. These results suggest that despite distinctive biophysical properties, the rat NICCs have indistinguishable pharmacological sensitivities to many organic blockers compared with T-type Ca(2+) channels.Keywords
This publication has 50 references indexed in Scilit:
- Multiple regulation by external ATP of nifedipine‐insensitive, high voltage‐activated Ca2+ current in guinea‐pig mesenteric terminal arterioleThe Journal of Physiology, 2002
- Effect of T-Type Selective Calcium Antagonist on Renal MicrocirculationHypertension, 2001
- Nerve evoked P2X receptor contractions of rat mesenteric arteries; dependence on vessel size and lack of role of L‐type calcium channels and calcium induced calcium releaseBritish Journal of Pharmacology, 2001
- Effects of mibefradil and nifedipine on arteriolar myogenic responsiveness and intracellular Ca2+British Journal of Pharmacology, 2000
- Mibefradil: A New Selective T-Channel Calcium Antagonist for Hypertension and Angina PectorisJournal of Cardiovascular Pharmacology and Therapeutics, 1997
- Identifying neuronal non-L Ca2+ channels – more than stamp collecting?Trends in Pharmacological Sciences, 1997
- Inhibition by mibefradil, a novel calcium channel antagonist, of Ca2+‐ and volume‐activated Cl− channels in macrovascular endothelial cellsBritish Journal of Pharmacology, 1997
- Antihypertensive Properties of the Novel Calcium Antagonist Mibefradil (Ro 40-5967)Hypertension, 1996
- Protein Kinase C Mechanism Enhances Vascular Muscle Relaxation by the Ca2+ Antagonist, Ro 40-5967Journal of Vascular Research, 1996
- In Vitro Pharmacologic Profile of Ro 40-5967, a Novel Ca2+ Channel Blocker with Potent Vasodilator but Weak Inotropic ActionJournal of Cardiovascular Pharmacology, 1989